Expression of cell cycle regulatory proteins in eyelid sebaceous gland carcinoma: Low p27 expression predicts poor prognosis

Experimental Eye Research

Volumn 118, Issue , 2014, Pages 46-52

  Kim, Namju ^a,b   Kim, Ji Eun ^a,c   Choung, Ho Kyung ^a,c   Lee, Min Joung ^d   Khwarg, Sang In ^a,e  

^a Seoul National University College of Medicine   (South Korea)

^b Seoul National University Bundang Hospital   (South Korea)

^c Seoul National University Boramae Hospital   (South Korea)

^d Hallym University   (South Korea)

^e Seoul National University Hospital   (South Korea)

Author keywords

Cell cycle; P27; Prognosis; Sebaceous gland carcinoma

Indexed keywords

CYCLIN D1; CYCLIN E; PROTEIN P16; PROTEIN P27; PROTEIN P53; REGULATOR PROTEIN;

ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISTANT METASTASIS; ELECTRONIC MEDICAL RECORD; EVISCERATION; EXCISION; EYELID; FEMALE; FOLLOW UP; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MALE; METASTASIS FREE SURVIVAL; OVERALL SURVIVAL; PATHOGENESIS; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; SEBACEOUS CARCINOMA; TISSUE MICROARRAY; TREATMENT RESPONSE;

EID: 84890112403     PISSN: 00144835     EISSN: 10960007     Source Type: Journal    
DOI: 10.1016/j.exer.2013.10.022     Document Type: Article

References (34)

1. Barnes N.L., Warnberg F., Farnie G., White D., Jiang W., Anderson E., Bundred N.J. Cyclooxygenase-2 inhibition: effects on tumour growth, cell cycling and lymphangiogenesis in a xenograft model of breast cancer. Br. J. Cancer 2007, 96:575-582.
2. Burns S.J., Foss A.J., Butler T.K. Outcome of periocular sebaceous gland carcinoma. Ophthal. Plast. Reconstr. Surg. 2005, 21:53-355.
3. Dasgupta T., Wilson L.D., Yu J.B. Aretrospective review of 1349 cases of sebaceous carcinoma. Cancer 2009, 115:158-165.
4. de Andrade B.A., Leon J.E., Carlos R., Delgado-Azanero W., Mosqueda-Taylor A., de Almeida O.P. Immunohistochemical expression of p16, p21, p27 and cyclin D1 in oral nevi and melanoma. Head Neck Pathol. 2012, 6:297-304.
5. Esposito V., Baldi A., De Luca A., Groger A.M., Loda M., Giordano G.G., Caputi M., Baldi F., Pagano M., Giordano A. Prognostic role of the cyclin-dependent kinase inhibitor p27 in non-small cell lung cancer. Cancer Res. 1997, 57:3381-3385.
6. Gonzalez-Fernandez F., Kaltreider S.A., Patnaik B.D., Retief J.D., Bao Y., Newman S., Stoler M.H., Levine P.A. Sebaceous carcinoma. Tumor progression through mutational inactivation of p53. Ophthalmology 1998, 105:497-506.
7. Gunia S., Kakies C., Erbersdobler A., Hakenberg O.W., Koch S., May M. Expression of p53, p21 and cyclin D1 in penile cancer: p53 predicts poor prognosis. J.Clin. Pathol. 2012, 65:232-236.
8. He S.M., Zhao Z.W., Wang Y., Zhao J.P., Wang L., Hou F., Gao G.D. Potential role of Jun activation domain-binding protein 1 and phosphorylated p27 expression in prognosis of glioma. Brain Tumor Pathol. 2012, 29:3-9.
9. Ho V.H., Ross M.I., Prieto V.G., Khaleeq A., Kim S., Esmaeli B. Sentinel lymph node biopsy for sebaceous cell carcinoma and melanoma of the ocular adnexa. Arch. Otolaryngol. Head Neck Surg. 2007, 133:820-826.
10. Jayaraj P., Sen S., Sharma A., Chosdol K., Kashyap S., Rai A., Pushker N., Bajaj M.S., Ghose S. Epigenetic inactivation of the E-cadherin gene in eyelid sebaceous gland carcinoma. Br. J. Dermatol. 2012, 167:583-590.
11. Karamitopoulou E., Zlobec I., Tornillo L., Carafa V., Schaffner T., Brunner T., Borner M., Diamantis I., Zimmermann A., Terracciano L. Differential cell cycle and proliferation marker expression in ductal pancreatic adenocarcinoma and pancreatic intraepithelial neoplasia (PanIN). Pathology 2010, 42:229-234.
12. Kim N., Kim J.E., Choung H.K., Lee M.J., Khwarg S.I. Expression of shh and wnt signaling pathway proteins in eyelid sebaceous gland carcinoma: clinicopathologic study. Invest. Ophthalmol. Vis. Sci. 2013, 54:370-377.
13. Kirla R.M., Haapasalo H.K., Kalimo H., Salminen E.K. Low expression of p27 indicates a poor prognosis in patients with high-grade astrocytomas. Cancer 2013, 97:644-648.
14. Kiyosaki K., Nakada C., Hijiya N., Tsukamoto Y., Matsuura K., Nakatsuka K., Daa T., Yokoyama S., Imaizumi M., Moriyama M. Analysis of p53 mutations and the expression of p53 and p21WAF1/CIP1 protein in 15 cases of sebaceous carcinoma of the eyelid. Invest. Ophthalmol. Vis. Sci. 2010, 51:7-11.
15. Kudahetti S.C., Fisher G., Ambroisine L., Prowse D., Kattan M.W., Foster C.S., Møller H., Oliver T., Fletcher A., Cooper C., Reuter V., Scardino P., Cuzick J., Berney D.M. Immunohistochemistry for p16, but not Rb or p21, is an independent predictor of prognosis in conservatively treated, clinically localised prostate cancer. Pathology 2010, 42:519-523. Transatlantic Prostate Group.
16. Li D.M., Sun H. PTEN/MMAC1/TEP1 suppresses the tumorigenicity and induces G1 cell cycle arrest in human glioblastoma cells. Proc. Natl. Acad. Sci. U S A. 1998, 95:15406-15411.
17. Loda M., Cukor B., Tam S.W., Lavin P., Fiorentino M., Draetta G.F., Jessup J.M., Pagano M. Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas. Nat. Med. 1997, 3:231-234.
18. Marsh K.L., Varley J.M. Frequent alterations of cell cycle regulators in early-stage breast lesions as detected by immunohistochemistry. Br. J. Cancer 1998, 77:1460-1468.
19. Matsuda Y., Ichida T., Genda T., Yamagiwa S., Aoyagi Y., Asakura H. Loss of p16 contributes to p27 sequestration by cyclin D(1)-cyclin-dependent kinase 4 complexes and poor prognosis in hepatocellular carcinoma. Clin. Cancer Res. 2003, 9:3389-3396.
20. McKaig R.G., Baric R.S., Olshan A.F. Human papillomavirus and head and neck cancer: epidemiology and molecular biology. Head Neck 1998, 20:250-265.
21. Morgan D.O. Cyclin-dependent kinases: engines, clocks, and microprocessors. Annu. Rev. Cell Dev. Biol. 1997, 13:261-291.
22. Nelson B.R., Hamlet K.R., Gillard M., Railan D., Johnson T.M. Sebaceous carcinoma. J.Am. Acad. Dermatol. 1995, 33:1-15.
23. Nieder C., Petersen S., Petersen C., Thames H.D. The challenge of p53 as prognostic and predictive factor in Hodgkin's or non-Hodgkin's lymphoma. Ann. Hematol. 2001, 80:2-8.
24. Porter P.L., Malone K.E., Heagerty P.J., Alexander G.M., Gatti L.A., Firpo E.J., Daling J.R., Roberts J.M. Expression of cell-cycle regulators p27Kip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients. Nat. Med. 1997, 3:222-225.
25. Pruneri G., Pignataro L., Carboni N., Buffa R., Di Finizio D., Cesana B.M., Neri A. Clinical relevance of expression of the CIP/KIP cell-cycle inhibitors p21 and p27 in laryngeal cancer. J.Clin. Oncol. 1999, 17:3150-3159.
26. Semczuk A., Jakowicki J.A. Alterations of pRb1-cyclin D1-cdk4/6-p16(INK4A) pathway in endometrial carcinogenesis. Cancer Lett. 2004, 203:1-12.
27. Sherr C.J., Roberts J.M. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev. 1999, 13:1501-1512.
28. Sihto H., Kukko H., Koljonen V., Sankila R., Böhling T., Joensuu H. Merkel cell polyomavirus infection, large T antigen, retinoblastoma protein and outcome in Merkel cell carcinoma. Clin. Cancer Res. 2011, 17:4806-4813.
29. Skomedal H., Kristensen G.B., Lie A.K., Holm R. Aberrant expression of the cell cycle associated proteins TP53, MDM2, p21, p27, cdk4, cyclin D1, RB, and EGFR in cervical carcinomas. Gynecol. Oncol. 1999, 73:223-228.
30. Supriatno, Harada K., Hoque M.O., Bando T., Yoshida H., Sato M. Overexpression of p27(Kip1) induces growth arrest and apoptosis in an oral cancer cell line. Oral Oncol. 2002, 38:730-736.
31. Takano Y., Kato Y., van Diest P.J., Masuda M., Mitomi H., Okayasu I. Cyclin D2 overexpression and lack of p27 correlate positively and cyclin E inversely with a poor prognosis in gastric cancer cases. Am. J. Pathol. 2000, 156:585-594.
32. Thakur A., Siedlak S.L., James S.L., Bonda D.J., Rao A., Webber K.M., Camins A., Pallàs M., Casadesus G., Lee H.G., Bowser R., Raina A.K., Perry G., Smith M.A., Zhu X. Retinoblastoma protein phosphorylation at multiple sites is associated with neurofibrillary pathology in Alzheimer disease. Int. J. Clin. Exp. Pathol. 2008, 1:134-146.
33. Wuarin J., Nurse P. Regulating S phase: CDKs, licensing and proteolysis. Cell 1996, 85:785-787.
34. Zhuang Y., Yin H.T., Yin X.L., Wang J., Zhang D.P. High p27 expression is associated with a better prognosis in East Asian non-small cell lung cancer patients. Clin. Chim. Acta 2011, 412:2228-2231.